PRESTIGE BRAND HOLDINGS INC

NYSE: PBH (Prestige Consumer Healthcare In)

Last update: 37 minutes ago

84.88

1.19 (1.42%)

Previous Close 83.69
Open 83.51
Volume 321,552
Avg. Volume (3M) 319,027
Market Cap 4,204,768,256
Price / Earnings (TTM) 19.92
Price / Earnings (Forward) 17.86
Price / Sales 3.81
Price / Book 2.35
52 Weeks Range
62.35 (-26%) — 90.04 (6%)
Earnings Date 12 May 2025 - 16 May 2025
Profit Margin 19.13%
Operating Margin (TTM) 31.68%
Diluted EPS (TTM) 4.26
Quarterly Revenue Growth (YOY) 2.70%
Quarterly Earnings Growth (YOY) 15.10%
Total Debt/Equity (MRQ) 57.43%
Current Ratio (MRQ) 3.68
Operating Cash Flow (TTM) 256.57 M
Levered Free Cash Flow (TTM) 191.75 M
Return on Assets (TTM) 6.19%
Return on Equity (TTM) 12.62%

Market Trend

Short Term Medium Term
Industry Drug Manufacturers - Specialty & Generic (US) Mixed Mixed
Drug Manufacturers - Specialty & Generic (Global) Mixed Mixed
Stock Prestige Consumer Healthcare In Bullish Bullish

AIStockmoo Score

0.5
Analyst Consensus 4.0
Insider Activity -1.5
Price Volatility -0.5
Technical Moving Averages 0.0
Technical Oscillators 0.5
Average 0.50

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
PBH 4 B - 19.92 2.35
CTLT 11 B - - 3.23
ZTS 76 B 1.05% 31.15 16.01
TAK 47 B 1,277.45% 34.11 0.950
HLN 46 B 1.56% 25.26 2.27
RDY 11 B 63.09% 18.04 2.90

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige’s key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer’s Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Investment Style Small Core
% Held by Insiders 1.30%
% Held by Institutions 108.73%

Ownership

Name Date Shares Held
Blackrock, Inc. 31 Dec 2024 8,430,726
Vanguard Group Inc 31 Dec 2024 5,690,159
Dimensional Fund Advisors Lp 31 Dec 2024 2,907,066
Ariel Investments, Llc 31 Dec 2024 2,762,023
Macquarie Group Ltd 31 Dec 2024 2,309,017
State Street Corp 31 Dec 2024 2,063,577
Victory Capital Management Inc 31 Dec 2024 1,662,668
Allspring Global Investments Holdings, Llc 31 Dec 2024 1,624,501
Geode Capital Management, Llc 31 Dec 2024 1,348,745
Kayne Anderson Rudnick Investment Management Llc 31 Dec 2024 1,087,620
Morgan Stanley 31 Dec 2024 1,085,793
Invesco Ltd. 31 Dec 2024 1,060,263
Congress Asset Management Co 31 Dec 2024 908,742
Boston Trust Walden Corp 31 Dec 2024 831,627
Northern Trust Corp 31 Dec 2024 813,076
52 Weeks Range
62.35 (-26%) — 90.04 (6%)
Price Target Range
93.00 (9%) — 104.00 (22%)
High 104.00 (DA Davidson, 22.53%) Buy
Median 100.00 (17.81%)
Low 93.00 (Oppenheimer, 9.57%) Buy
Average 99.00 (16.64%)
Total 3 Buy
Avg. Price @ Call 86.56
Firm Date Target Price Call Price @ Call
Oppenheimer 13 Feb 2025 93.00 (9.57%) Buy 85.68
Canaccord Genuity 07 Feb 2025 100.00 (17.81%) Buy 87.00
DA Davidson 07 Feb 2025 104.00 (22.53%) Buy 87.00
Name Avg. Buy ($) Avg. Sell ($) Net Quantity Net Value ($)
FRITZ MARY BETH - 86.86 -1,678 -145,751
Aggregate Net Quantity -1,678
Aggregate Net Value ($) -145,751
Aggregate Avg. Buy ($) -
Aggregate Avg. Sell ($) 86.86
Name Holder Date Type Quantity Price Value ($)
FRITZ MARY BETH Officer 10 Mar 2025 Sell (-) 1,678 86.86 145,751

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria